|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.36 EUR | +5.19% |
|
+9.07% | +24.18% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability (Composite) | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
| 7.7B | ||||||
| 77.69B | ||||||
| 57.88B | ||||||
| 52.56B | ||||||
| 37.85B | ||||||
| 19.7B |
- Stock Market
- Equities
- GRF Stock
- Charts Grifols, S.A.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition